PUBLISHER: Mordor Intelligence | PRODUCT CODE: 2116495
PUBLISHER: Mordor Intelligence | PRODUCT CODE: 2116495
According to Mordor Intelligence, the global dental suture market size in 2026 is estimated at USD 239.24 million, growing from 2025 value of USD 224.68 million with 2031 projections showing USD 327.54 million, growing at 6.48% CAGR over 2026-2031.

This report is Segmented by Suture Type (Absorbable, Non-Absorbable), Material (Synthetic Material, Natural Material), Patient Age Group (Up To 17 and More), Application (Tooth Extraction, Periodontal Procedure, and More), End-Use (Dental Clinics, Hospitals, Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and More). The Market Forecasts are Provided in Terms of Value (USD).
More than 1 billion people were affected by periodontal disease in 2024, and epidemiological modeling anticipates 1.56 billion cases by 2050. Disease incidence rises sharply with age and displays pronounced socioeconomic variation, which leads to a diverse set of clinical protocols that rely on precise tissue approximation to curb bacterial infiltration. Surgical guidelines emphasize premium suture selection as a non-negotiable tool for flap stability, especially in patients with comorbid diabetes or cardiovascular conditions that complicate healing.
U.S. implant prevalence was 5.7% in 2016 and is anticipated to reach as high as 23% by 2026 if accessibility trends continue. Implants usually mandate several suturing episodes-including initial fixture placement, membrane fixation, and soft-tissue reshaping-which multiply suture use per patient. Positioning errors persist in 56.6% of implant cases, leading to revision surgeries that further augment suture demand.
Clinical trials show intraoral cyanoacrylate can secure 71.97% root coverage in periodontal surgery compared with 61.36% for sutures, while reducing closure time from 7.31 minutes to 2.16 minutes. Adhesives also eliminate removal appointments, a cost advantage in high-volume practices. Their growing acceptance threatens routine suture volumes, particularly for small incisions.
Other drivers and restraints analyzed in the detailed report include:
For complete list of drivers and restraints, kindly check the Table Of Contents.
Non-absorbable filaments held 54.10% of the dental suture market in 2025, yet absorbable variants are forecast to deliver the leading 6.78% CAGR to 2031. The absorbable category benefits from synthetic polymers that offer controlled degradation and tensile retention matching tissue-healing kinetics. Dental suture market size for absorbable lines is projected to expand as regulatory frameworks validate their biodegradation profiles. Because removal appointments disappear, clinics gain scheduling flexibility and lower chair-time per patient, reinforcing uptake.
Polyglactin and polyglycolic-acid braids now achieve tensile strengths comparable to silk and nylon while provoking lower tissue reactivity, a critical feature in the oral cavity's microbe-rich milieu. As product portfolios widen to include monofilament designs for esthetic zones, the adoption curve steepens. Over the forecast horizon, non-absorbable will continue to dominate specific indications that demand permanent tensile support, yet their share is expected to erode gradually in favor of absorbables.
Synthetic fibers accounted for 59.62% of 2025 revenue and are projected to compound at 7.02% annually through 2031, maintaining clear leadership in the dental suture market. Their low bacterial retention and consistent absorption rates outperform natural alternatives, especially important in procedures where infection control is paramount. Conversely, natural offerings such as silk or cellulose retain niche relevance for patients sensitive to chemical additives.
The regulatory push for eco-friendly materials is catalyzing hybrid R&D that bonds synthetic strength with plant-derived substrates. Early prototypes of cellulose-reinforced polylactide braids suggest a credible bridge between performance and sustainability demands. While not yet commercialized, such products could shift buyer criteria toward environmental credentials.
North America generated 36.90% of global revenue in 2025, anchored by high procedural volumes, robust insurance coverage, and practitioner familiarity with premium materials. United States-specific initiatives on opioid-sparing analgesia, such as the 2025 approval of suzetrigine, help safeguard patient comfort and promote elective procedures. Recent 10% tariffs on imported dental consumables may shift sourcing toward local suture manufacturers, but the market remains attractive given a 7.05% regional CAGR through 2031. Asia-Pacific represents the fastest 7.25% CAGR trajectory thanks to rising disposable income, urbanization, and large-scale public health investments. While per-capita procedure rates are lower than in North America, the vast population base translates to unparalleled volume potential. Domestic firms in India, China, and South Korea are scaling capacity to meet demand while offering cost-competitive alternatives. Europe recorded a steady 6.80% annual growth, buoyed by single-payer insurance schemes that cover a baseline of restorative care. Strict environmental policy accelerates the shift to biodegradable filaments. Local content regulations in France and Germany stimulate intra-regional production, offering European brands a competitive edge over imports. Latin America and the Middle East & Africa display 6.33% and 5.95% growth rates, respectively. Economic volatility is a recurring challenge, yet targeted government programs-such as Brazil's Expanded National Oral Health Policy-create pockets of accelerated uptake. GCC countries leverage medical tourism to attract affluent patients seeking advanced aesthetic restoration, supporting premium suture consumption.